Hellenic Institute for the Study of Sepsis
30
5
7
20
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 30 trials
100.0%
+13.5% vs industry average
27%
8 trials in Phase 3/4
5%
1 of 20 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (30)
Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection
Role: lead
Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.
Role: lead
Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe Infections (the MODIFY Trial)
Role: lead
Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
Role: lead
Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)
Role: lead
Emapalumab Treatment For Anticipated Clinical Benefit In Sepsis Driven By The Interferon-Gamma Endotype (The EMBRACE Trial)
Role: lead
The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Post-acute Phase of the Infection by Covid-19
Role: lead
Viscoelastic Coagulation for Early Sepsis Detection
Role: lead
Personalized Immunotherapy in Sepsis
Role: lead
Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
Role: lead
NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification
Role: lead
Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO
Role: lead
Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia
Role: lead
Addressing Personalized Needs in Clostridioides Difficile Infection
Role: lead
suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)
Role: lead
STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care
Role: lead
The Benefit of Bermekimab in Patients With Systemic Sclerosis
Role: lead
suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19
Role: lead
Bacillus Calmette-guérin Vaccination to Prevent COVID-19
Role: lead
Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early
Role: lead